Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

Last week, after Musk saw a huge drop in a single day (not unrelated to the market-wide fall caused by Trump’s tariffs and ...

The esteemed initiative equips early-career scientists with leadership training and networking opportunities COLUMBUS, Ohio, ...

According to an attorney for a detained Venezuelan asylum-seeker, her client’s deportation was justified because he had a ...

No human has ever picked a perfect bracket. So, we gave the job to the world's most advanced AI models to do it for us.

U.S. Energy Secretary Chris Wright has signaled a change that could mean the difference between life and death for millions ...

On January 6, 2025, the Society for Maternal Fetal medicine ("SMFM") published an abstract reporting topline results for Sera's Prematurity Risk Assessment Combined With Clinical Interventions for ...

Graphic design students at University of Wisconsin-Stout collaborate with Epic Systems to improve patient and healthcare ...

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by ...

By Lisa Friedman The Environmental Protection Agency plans to eliminate its scientific research arm, firing as many as 1,155 chemists, biologists, toxicologists and other scientists, according to ...

A French researcher was denied entry to the U.S. over text messages on his phone that were critical of President Donald Trump ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on rare diseases, today announced that results from its Phase 2 FIGHT DMD clinical ...